Skip to content

Walnut trials found lower ApoB, without clear blood-pressure changes

Pooling randomized trials suggested a change in a blood marker, while results for another apolipoprotein and both blood-pressure measures were statistically inconclusive.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Walnut interventions lowered apolipoprotein B, or ApoB, in the pooled analysis. The review did not find statistically significant changes in ApoA1 or either blood-pressure measure. This supports a limited conclusion about a measured blood marker; it does not show that walnuts prevent cardiovascular events or reliably lower blood pressure.

Keep in mind

The abstract omits units for its pooled estimates, along with intervention lengths, walnut amounts and comparator diets. These gaps prevent a clear interpretation of the change's size or practical importance.

THE RESULT, WITH CONTEXT

What researchers found

Statistically significant decrease

ApoB blood level

Walnut interventions versus trial comparison groups; study durations and comparator diets were not described. The abstract omits the measurement units.

Endocrinol Diabetes Metab, 2026 · Original source ↓

A specific marker result

The researchers combined randomized trials and evaluated apolipoproteins alongside blood pressure. The significant result was specific to ApoB, so the outcomes should be considered separately when judging what this review actually found.

Blood-pressure effects remain uncertain

The blood-pressure estimates had confidence intervals compatible with both decreases and increases. Their lack of statistical significance leaves uncertainty about effects; it does not establish that walnut intake and the comparison conditions are equivalent.

CHECK THE ORIGINAL

The original publication

Does Walnut Supplementation Have Favourable Effect Apolipoprotein A, B and Blood Pressure? A Systematic Review, Meta-Analysis and Meta-Evidence of Randomised Clinical Trials.

Musazadeh V, Mahmoudinezhad M, Hosseini-Roknabadi SM et al.
Endocrinol Diabetes Metab · 2026

PubMed ID
41858294
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.